Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome

NCT07228403 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome (SBS)

Interventions

DRUG: Glepaglutide 10 mg

Sponsor

Zealand Pharma